U.S. Bioscience, Schering-Plough deal

The companies amended their 1993 distribution agreement for UBS's Ethyol (amifostine), a cytoprotective agent. Under the revised agreement, Schering will purchase the product from UBS at a price based on a percent of net sales and UBS will no longer absorb certain promotional expenses previously shared by the parties. ...